THE WHAT? IFF has announced the appointment of Frank Clyburn to succeed Andreas Fibig as CEO and a member of the Board of Directors, effective February 14, 2022. The company will also separate the Chairman and Chief Executive roles, with Dale Morrison assuming the role of non-executive Chairman of the Board of Directors.

THE DETAILS Clyburn will join the flavors and fragrances giant from Merck & Co where he serves as Executive Vice President and Vice President of Human Health.

“I am honored to serve as IFF’s next CEO,” said Frank Clyburn, newly appointed Chief Executive Officer. “This is an iconic company and industry leader with tremendous opportunity to deliver outstanding customer experience and long-term, sustainable growth. The purpose and vision of IFF is very closely linked with accelerating global trends of nutrition, wellness and sustainability, which means that together, colleagues around the world can deliver significant value for both customers and shareholders. Working with IFF’s world-class talent, unrivalled offerings and impressive innovation platform, I am excited to bring my approach to executional excellence to capitalize on IFF’s bright future.”

THE WHY? Dale Morrison, IFF Director, commented, “Frank is the best executive to lead IFF into its next chapter at the pace we need. His strong operating experience plus his hands-on approach and customer-centric perspective will accelerate the execution of IFF’s strategic and operating priorities.” 

Ed Breen, IFF Director, added, “Frank joins IFF at a time when there are significant value creation opportunities ahead of us. We are confident in his ability to unlock profitable growth, capture synergies, maximize the N&B integration and optimize IFF’s portfolio to deliver strong value for shareholders.”